A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Resources
A collection of feature articles, case studies, and whitepapers from CAS. News and trends spanning scientific research and information technology.
Resources Index
Blog
Mind the Gap: Future-Proof Your IP Strategy for Innovation and Risk Management
Just how resilient is your intellectual property strategy? Given the growing commercial importance of intellectual property (IP) assets and the dynamic nature of the modern R&D landscape, it’s a critical question that many businesses simply can’t ignore.
Blog
Beating COVID-19: Insights and strategies for new vaccines and therapies
The outbreak of COVID-19, caused by the new virus SARS-CoV-2, has spread rapidly across the world. Since the first report from Wuhan, China on December 31, 2019, the total numbers of confirmed cases and COVID-19-related deaths worldwide have continued to escalate. Now declared a pandemic by the World Health Organization (“WHO”), COVID-19 has already overwhelmed healthcare systems in many countries and is expected to impose a major impact on the world economy.
Press Releases
CAS and PatSnap Forge Strategic Partnership that Unites Market-leading Scientific Content and AI-powered Technology to Accelerate Global Innovation
This CAS and PatSnap partnership unites market-leading scientific content and AI-powered technology to accelerate global innovation. Collaboration strengthens leading sci-tech information solutions to deliver enhanced insight across R&D and IP workflows.
Blog
Improve Efficiencies and Mitigate Risk with Comprehensive IP Searches for Formulations
Obtaining accurate and reliable intellectual property (IP) information can make or break a company’s success. To minimize the risk of patent rejections and avoid inadvertent infringement on an existing patent, formulations IP searching is an integral component of the product development pipeline.
Case Studies
Driving Innovation with Data: Preserving Brazil’s Biodiversity
In this case study, learn how CAS collaborated with natural product researchers in Brazil to build an accessible data collection, representing over 54,000 substances from Brazilian biodiversity.
Blog
Outsourcing formulation development requires better access to right data early in process
The demand for outsourcing pharmaceutical formulation development and manufacturing is on the rise for drug developers at all levels, especially in emerging markets like India. Frost & Sullivan estimates the global contract research organization (CRO) market will reach $64.58 billion by 2021.
Press Releases
Syngenta Invests in SciFinderⁿ from CAS to Enhance Research Efficiency and Bring Sustainable Agricultural Solutions to Market Faster
Syngenta invests in SciFinderⁿ from CAS to enhance research efficiency and bring sustainable agricultural solutions to market faster. Advanced scientific information solutions proving to be a critical driver of productivity for leading innovators as the volume of published scientific data grows.
Blog
The importance of celebrating diversity in STEMM
The composition of people in leadership positions, particularly in the fields of science, technology, engineering, mathematics and medicine, is often lacking representation of minorities groups. Women and other subgroups remain highly underrepresented on boards and panels, in faculty positions and senior corporate roles. Even though the percentage of women obtaining a science or engineering degree has increased in the last decades, the number of women in leading positions in industry and academia is lagging behind.
Press Releases
CAS Rolls Out New Predictive Retrosynthetic Capabilities in SciFinderⁿ
As part of the continued commitment to helping R&D leaders accelerate scientific discovery, CAS announced the launch of a breakthrough retrosynthetic capability in SciFinderⁿ . This computer-aided synthetic design (CASD) solution utilizes AI technology, powered by CAS’s unmatched collection of scientist-curated reaction content and leverages John Wiley and Sons, Inc.’s award-winning ChemPlanner technology to now identify predicted retrosynthetic routes for both known and novel compounds.